A detailed history of Envestnet Asset Management Inc transactions in Glaukos Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 56,195 shares of GKOS stock, worth $8.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,195
Previous 67,936 17.28%
Holding current value
$8.48 Million
Previous $8.04 Million 8.94%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$113.62 - $135.39 $1.33 Million - $1.59 Million
-11,741 Reduced 17.28%
56,195 $7.32 Million
Q2 2024

Aug 08, 2024

BUY
$89.48 - $118.35 $209,472 - $277,057
2,341 Added 3.57%
67,936 $8.04 Million
Q1 2024

May 13, 2024

SELL
$76.4 - $96.33 $1.07 Million - $1.35 Million
-14,011 Reduced 17.6%
65,595 $6.18 Million
Q4 2023

Feb 13, 2024

SELL
$59.53 - $85.11 $1.31 Million - $1.87 Million
-21,996 Reduced 21.65%
79,606 $6.33 Million
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $1.57 Million - $1.79 Million
22,652 Added 28.69%
101,602 $7.65 Million
Q2 2023

Aug 04, 2023

BUY
$45.44 - $71.21 $217,021 - $340,098
4,776 Added 6.44%
78,950 $5.62 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $584,569 - $699,138
13,322 Added 21.89%
74,174 $3.72 Million
Q4 2022

Feb 07, 2023

SELL
$40.82 - $57.75 $270,432 - $382,593
-6,625 Reduced 9.82%
60,852 $2.66 Million
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $1.04 Million - $1.3 Million
22,227 Added 49.12%
67,477 $3.59 Million
Q2 2022

Aug 03, 2022

SELL
$34.86 - $63.77 $208,706 - $381,790
-5,987 Reduced 11.68%
45,250 $2.06 Million
Q1 2022

May 04, 2022

BUY
$44.33 - $57.82 $503,101 - $656,199
11,349 Added 28.45%
51,237 $2.96 Million
Q4 2021

Feb 04, 2022

BUY
$40.27 - $56.99 $125,279 - $177,295
3,111 Added 8.46%
39,888 $1.77 Million
Q3 2021

Oct 07, 2021

BUY
$47.43 - $84.23 $27,129 - $48,179
572 Added 1.58%
36,777 $1.77 Million
Q2 2021

Aug 04, 2021

BUY
$73.06 - $97.7 $411,473 - $550,246
5,632 Added 18.42%
36,205 $3.07 Million
Q1 2021

May 04, 2021

BUY
$70.43 - $97.42 $1.37 Million - $1.89 Million
19,417 Added 174.05%
30,573 $2.57 Million
Q4 2020

Feb 02, 2021

SELL
$48.9 - $75.26 $110,367 - $169,861
-2,257 Reduced 16.83%
11,156 $840,000
Q3 2020

Oct 09, 2020

SELL
$37.23 - $50.97 $103,685 - $141,951
-2,785 Reduced 17.19%
13,413 $664,000
Q2 2020

Jul 08, 2020

SELL
$28.78 - $46.83 $555,713 - $904,240
-19,309 Reduced 54.38%
16,198 $622,000
Q1 2020

Apr 23, 2020

BUY
$25.53 - $70.14 $190,530 - $523,454
7,463 Added 26.61%
35,507 $1.1 Million
Q4 2019

Feb 11, 2020

SELL
$54.18 - $65.64 $3,250 - $3,938
-60 Reduced 0.21%
28,044 $1.53 Million
Q3 2019

Oct 17, 2019

BUY
$58.58 - $83.91 $659,142 - $944,155
11,252 Added 66.77%
28,104 $1.76 Million
Q2 2019

Aug 02, 2019

BUY
$63.59 - $78.71 $299,508 - $370,724
4,710 Added 38.79%
16,852 $1.27 Million
Q1 2019

May 10, 2019

SELL
$50.75 - $80.54 $53,490 - $84,889
-1,054 Reduced 7.99%
12,142 $952,000
Q4 2018

Feb 13, 2019

BUY
$52.18 - $67.93 $688,567 - $896,404
13,196 New
13,196 $741,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.